A machine learning model using routine clinical data more accurately predicted 5-year heart failure risk in patients with CKD ...
The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...
Polymers dominated the market in 2025, capturing a significant share due to their versatility in aerospace, automotive, and ...